ClinicalTrials.gov
ClinicalTrials.gov Menu

Beijing Percutaneous Coronary Intervention Registry (BJPCI Registry)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01417325
Recruitment Status : Recruiting
First Posted : August 16, 2011
Last Update Posted : January 25, 2018
Sponsor:
Information provided by (Responsible Party):
Yuejin Yang, Chinese Academy of Medical Sciences, Fuwai Hospital

Brief Summary:
The registry study is to obtain the state of the art of the percutaneous coronary intervention state treatment for coronary heart disease in Beijing area of P.R.China in a real world. The data are collected from 48 hospitals in Beijing area using an uploading system through internet.

Condition or disease
Coronary Heart Disease

Study Type : Observational
Estimated Enrollment : 700000 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: A Registry Study of Percutaneous Coronary Intervention Treatment in Beijing Area of P.R. China
Study Start Date : January 2010
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Diseases
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All the patients receiving coronal artery angiography or percutaneous coronary intervention therapy in selected 48 hospitals of Beijing, P.R.China.
Criteria

Inclusion Criteria:

  • Patients from selected 48 hospitals of Beijing, P.R.China
  • Patients receiving coronal artery angiography or percutaneous coronary intervention therapy

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01417325


Contacts
Contact: Yuejin Yang, Doctor 8610-68314466 yangyjfw@yahoo.com.cn
Contact: Lei Song, Doctor 8610-13910968125 drsongfw@gmail.com

Locations
China, Beijing
Beijing cardiovascular intervention quality control and improvement center Recruiting
Beijing, Beijing, China, 100037
Contact: Yuejin Yang, doctor    8610-88398800    yangyjfw@yahoo.com.cn   
Contact: Lei Song, doctor    8610-13910968125    drsongfw@gmail.com   
Sponsors and Collaborators
Chinese Academy of Medical Sciences, Fuwai Hospital
Investigators
Study Chair: Yuejin Yang, doctor Fuwai Heart Hospital & Cardiovascular Institute

Responsible Party: Yuejin Yang, Director of coronary heart disease center, vice president of Fuwai hospital, Chinese Academy of Medical Sciences, Fuwai Hospital
ClinicalTrials.gov Identifier: NCT01417325     History of Changes
Other Study ID Numbers: Bciqcic-fw-01
First Posted: August 16, 2011    Key Record Dates
Last Update Posted: January 25, 2018
Last Verified: January 2018

Additional relevant MeSH terms:
Heart Diseases
Coronary Disease
Coronary Artery Disease
Myocardial Ischemia
Cardiovascular Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases